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ABSTRACT 
Intervertebral Disc Degeneration (IVDD) is a complex phenomenon 
characterizing the desiccation and structural compromise of the primary joint in the 
human spine. The intervertebral disc (IVD) serves to connect vertebral bodies, cushion 
shock, and allows for flexion and extension of the vertebral column. Often presenting in 
the 4
th
 and 5
th
 decade of life as low back pain, this disease was originally believed to be 
the result of natural “wear and tear” coupled with repetitive mechanical insult, and as 
such many studies focus on patients between 40 and 50 years of age. Research over the 
past two decades, however, has demonstrated that environmental factors have only a 
modest effect on disc degeneration, with genetic influences playing a much more 
substantial role. Extensive research has focused on this process, though definitive risk 
factors and a clear pathophysiology have proved elusive. The aim of this study was to 
assemble a cohort of patients exhibiting definitive signs of degeneration that were well 
below the average age of presentation with minimal to no exposure with suspected 
environmental risk factors and conduct a targeted genome analysis in an attempt to 
elucidate a common genetic component. Through whole genome sequencing and analysis 
the results corroborated findings in a previous study, as well as demonstrated a potential 
connection and influence between mutations found in IVD structural or functional genes, 
and the provocation of IVDD. Though the sample size was limited in scale and age, these 
findings suggest further IVDD research into the association of variants in collagen, 
aggrecan and the insulin-like growth factor receptor genes of young patients with an early 
onset of disc degeneration and minimal exposure to suspected risk factors is merited.   
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Chapter 1 
INTRODUCTION 
1.1 Overview 
Intervertebral Disc Disease (IVDD) is a diverse affliction that characterizes a 
structural failure of the intervertebral discs that provide mechanical support to the 
vertebral column. Intervertebral discs play a significant role in the support, durability, 
and flexibility of the spine (Adams et al., 2006), and disorders in relation to disc 
degeneration are common causes of morbidity and life quality deterioration 
(Frymoyer et al., 1992). As these discs become mechanically incompetent the spine 
becomes unstable and loses the ability to properly distribute weight. When this 
instability occurs in the lumbar discs of the lower back, it is one of the most common 
causes of low back pain (Benneker et al.), affecting as much as 80% of the population 
(Luo et al., 2004) with around 10% of patients becoming chronically disabled 
(Maniadakis et al., 2000).  The etiology of IVDD was traditionally viewed as a result 
of “wear and tear” from mechanical injuries and other factors such as gender, 
occupation, cigarette smoking and exposure to vehicular vibration (Ala-kokko et al., 
2002). However studies over the past 15 years have begun to suggest that 
degeneration is determined to a large extent, instead, by genetic influences 
(Sambrook et al., 1999).  
1.2 Structure of the Intervertebral Disc 
Intervertebral discs (IVDs) are the largest avascular tissues in the body and are 
positioned between the vertebral bodies acting as the main joints in the spinal column. 
There are a total of 23 discs throughout the spine, constituting approximately one-
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third of the total length. Each disc is 8 to 10mm thick and 4cm in diameter. The discs 
lie between each vertebrae starting at the third cervical body (C-3) and extending 
down through the thoracic and lumbar region with the last disc between the final 
lumbar body (L-5) and the first sacral vertebrae (S-1). As greater pressure is exerted 
on the base of the spine, the thickness and surface area of the discs is greatest in the 
lumbar region and thinnest in the cervical levels, they are otherwise remarkably 
similar in composition and function (Coventry et al., 1945). The primary role of the 
disc is to evenly transmit loads generated from the body’s weight and muscle 
movements through the vertebral column. The discs also function to create space 
between each vertebrae allowing for passage of the neural roots of the spinal cord and 
proper orientation of the facet joints (Pye et al., 2007).The IVD contain a multitude of 
chondrocyte-like and fibroblast-like cells, each of which is difficult to categorize into 
a distinct phenotype (Roberts et al., 2002). The discs are composed of three major 
components, the cartilaginous endplate (CEP), the annulus fibrosus (AF), and the 
nucleus pulposus (NP).  
1.2.1 The Annulus Fibrosus  
The outermost morphologically distinct region of the IVD is a series of 15-25 
concentric rings, or lamellae, termed the annulus fibrosus. The rigid ring structure of 
the AF encompasses the NP allowing for the even distribution of pressure to 
neighboring vertebrae.  The primary function of the AF is to withstand the tension 
created during deformation of the NP (Whatley et al. 2012). The exterior of the AF is 
firmly affixed to the CEP and contains the few sensory nerves of the IVD (Adams et 
al., 2006). The AF is composed of type I and II collagen and can be separated into 
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inner and outer sections. The inner AF must resist high hydrostatic pressure from the 
shifting of the NP under pressure and is composed of widely spaced lamellae 
(Antoniou et al., 1996). The outer lamella is subjected to more tensile stress and thus 
the layers are more closely packed and are highly organized (Shankar et al., 2009). 
While the two sections are composed of both type I and II collagen, the proportion of 
type I collagen increases from the inner part toward the outer annulus, while type II 
follows the opposite distribution (Kraemer et al., 1995).  
The collagen fibers of the AF are oriented parallel to lamellae and at 60 degree 
angles to the vertical axis (Figure 2) (Raj et al., 2008). The orientation of the angles to 
the vertical axis alternates to the right and left with each successive layer, with the 
outermost layer highly organized at 60 degrees and gradually reducing to 45 degrees 
in the inner layers (Cassidy et al., 1989), providing optimal tensile strength for 
containment of the NP (Walker et al., 2004). Each lamella is bound to adjacent layers 
via radially extending elastin fibers that also contribute to the ability of the AF to 
return to its original arrangement following flexion or extension of the spine. The 
cells of the outer AF are fibroblast-like, elongated, thin, and aligned parallel to the 
collagen fibers, while those of the inner lamellae are also thin and elongated, but 
strictly chondrocyte-like (Urban et al., 2003). The dry weight of the AF consists of 
50-70% collagen, 10-20% proteoglycans, and 10-15% noncollagenous proteins 
(Bruehlmann et al., 2002).   
1.2.2 The Nucleus Pulposus  
The nucleus pulposus is the gelatinous structure contained within the AF and 
sandwiched between the superior and inferior CEP.  The NP resists and evenly 
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redistributes the compressive forces transmitted through the spine. The vast majority 
of the NP is composed of water, constituting 75-90% of the wet weight (Horner et al., 
2002), this allows for the compressive loads to be transmitted hydrostatically 
throughout the interior of the AF and internal regions of the CEP, substantially 
reducing pressure on the AF and CEP interface (Figure 3). As the consistency of the 
NP is gel-like, it is much less dense than the AF. These two properties give the IVD 
its viscoelasticity and compressive strength which exceeds that of the neighboring 
osseous end plates (Walker et al., 2004).  
The NP is composed of a large amount of proteoglycans, collagen, elastin, and 
chondrocyte-like cells (Shankar et al., 2009). Randomly organized collagen fibers and 
radially extending elastin fibers, comprising 25% and 2% of the dry weight 
respectively and hold the proteoglycan containing gel in place (Zhao et al., 2007). 
The chief proteoglycan of the NP is aggrecan, which aggregates to with hyaluronic 
acid, and contains the glycosaminoglycans (GAGs) keratin sulfate (KS) and 
chondroitin sulfate (CS) (McDevitt et al., 1988).  Due to the large negative charge of 
the GAG chains in the proteoglycan molecules, water is bound within the NP 
allowing for a higher level of hydration than would otherwise be osmotically 
favorable (Yu et al., 2007). The cells of the NP are chondrocyte-like with larger 
cytoplasmic volume and more rounded than those found in the inner AF (Lee et al., 
2007). The primary collagen found in the NP is type II, with the largest concentration 
at the center and being replaced with type I toward the periphery (Cassinelli et al., 
2000), in a similar manner to that of the AF. While aggrecan makes up the majority of 
the proteoglycans found throughout the NP and makes the largest contribution to 
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hydration, other proteoglycans are still essential as they are involved in matrix repair 
(Shankar et al., 2009). 
1.2.3 The Cartilaginous Endplate  
The most superior and inferior regions of the disc are a thin 1mm thick layer of 
horizontal hyaline cartilage known as the cartilaginous endplates. The CEP is the 
interface between the osseous vertebral endplate of the vertebral bodies, the caudal 
and cephalic aspects of the AF, and the NP, serving as the gateway for nutrient and 
waste exchange with the disc (Moon et al., 2013). Early in life the CEP is highly 
vascularized with significant reductions being seen one year after birth, and almost no 
blood vessels being present by age 30 (Raj, 2008). As these vascular channels 
decrease the NP begins to rely on simple diffusion across the CEP to supply nutrients 
and export waste, leading to increasingly inefficient exchange. Nutrient exchange 
must then occur through capillary buds of the neighboring vertebrae which pass 
through small marrow contact channels that penetrate the calcified layer of the 
vertebral osseous endplate, but do not enter the CEP (Nachemson et al., 1970). This 
process results in poor nutrient exchange and is highly implicated in disc 
degeneration (Martin et al., 2002). 
Another important function of the CEP is to distribute intradiscal pressures to 
adjacent vertebrae, thus preventing the NP from bulging into the underlying 
trabecular bone (Brinckmann et al., 1983).  As the spine carries substantial forces and 
the discs are not vascularized, the CEP must balance the opposing biophysical 
requirements of being strong enough to prevent vertebral fracture, yet porous enough 
to allow diffusion from vertebral capillaries to the IVD cells (Lotz et al., 2013). The 
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CEP is attached to the AF by collagen fibers that run horizontal and parallel to the 
vertebral body and extend into the disc, fixing the structure in place. Like most 
articular cartilage, the CEP is composed of chondrocytes interspersed with 
proteoglycans and type I and II collagen fibers (Roughley et al., 2006). 
1.3 Studying Intervertebral Disc Degeneration 
There is no clear and widely accepted definition for disc degeneration (Freemont 
et al., 2009). This arises, in part, from the various ways in which disc degeneration is 
observed. To a radiologist loss of signal intensity or osteophyte proliferation can be 
diagnostic, for a biochemist changes in hydration or aggrecan content is indicative, 
and then to a pathologist the presence of fissures or a prolapse demonstrate 
degeneration. As degenerated disc and aging disc share many similar features, and it 
is difficult to differentiate changes that occur exclusively due to aging and those that 
are pathological (Urban et al., 2003) Adams et al. proposed a definition, suggesting 
that disc degeneration is “an aberrant, cell-mediated response to progressive structural 
failure” and defining a degenerate disc as “one with structural failure combined with 
accelerated or advanced signs of aging” (Adams et al., 2006). A universally accepted 
etiology of IVDD has proved equally difficult to establish. Studies implicate several 
risk factors for developing IVDD including; a genetic predisposition, impaired 
metabolite transport, mechanical strain, nutrition, tobacco use, alterations of matrix 
degradation / synthesis, inflammation, cell senescence, an inactive lifestyle, 
weightlifting, and aging (Raj et al., 2008; McNally et al., 1992; Battie et al., 1995; 
Battie el at., 1991; Pope et al., 1998).  
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In addition to a lack of a fully accepted definition of IVDD, studies aiming to 
elucidate a disease pathway are further confounded by the lack of an appropriate 
animal model organism (Urban et al., 2003). The primary difference between animal 
and human spines is the horizontal orientation of most animal spines, resulting in 
substantially different weight distribution. In rodents and most mammals, the NP is 
populated by notochordal cells throughout their life, while these cells disappear in 
humans after infancy. It has been demonstrated that in these animals the cells produce 
and maintain a high degree of sulphated GAGs and low collagen content, 
distinguishing them from IVDs found in humans (Butler et al., 1989). Furthermore in 
humans the CEP acts as a growth plate for the vertebral body, where in most animals 
a separate growth plate exists and the CEP is substantially thinner (Urban et al., 
2003). Consequently, most information on the etiology of IVDD to date has come 
from human studies.  
1.3.1 Healthy vs. Degenerate Discs 
There are substantial changes in the morphology of the human IVD with both 
aging and degeneration. Disc degeneration involves both cell-mediated changes as 
well as structural disruptions, but which precedes the other is not clear (Modic et al., 
2007). The three factors believed to play a role in IVDD are mechanical, nutritional, 
and genetic, each to a various extent (Modic et al., 2007). During degeneration the NP 
experiences changes in cell composition, hydration, and volume, becoming more 
fibrotic, and the boundary between the NP and AF becoming less distinct 
(Buckwalter et al., 1995). The structure and organization of the AF also experiences 
changes, with the lamellae becoming irregular, bifurcating and interdigitating, and the 
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collagen and elastin networks becoming increasingly disorganized (Urban et al., 
2003). The CEP of the IVD becomes sclerotic, loses vascular contact and exhibits 
decreased permeability (Buckwalter et al., 1995).  
As the largest mostly avascular tissue in the body, nutrient transport has long been 
suggested as a causative factor of IVDD (Nachemson et al., 1970). The healthy adult 
disc has few, if any, blood vessels, all of which are restricted to the periphery of the 
outer annulus. These vessels, in conjunction with the capillary beds of the 
surrounding soft tissue, provide the AF with sufficient nutrition (Horner et al., 2001). 
However, in the NP, metabolite transport relies on the capillaries of the vertebral 
body. These molecules must utilize simple diffusion to cross the CEP, and then 
penetrate the dense disc matrix, with cells in the center of the NP distanced up to 
8mm from the closest vessel (Katz et al., 1986). Although transport across the CEP 
relies on the concentration gradient generated from disc cell metabolism, the 
viscoelastic properties of the AF allow for some distribution throughout the disc by 
convective fluid flow as a result of mechanical disc compression and recovery (Lotz 
et al., 2013).  Cells form only about 1% of the entire volume of the IVD (Le Maitre et 
al., 2007), thus when unimpeded, this supplies adequate exchange for the metabolic 
needs of the disc (Holm et al., 1981). Although constituting the vast minority of the 
disc, the roles of IVD cells are vital to proper function, as they maintain and produce 
the components of the extracellular matrix (ECM) and control matrix synthesis and 
degradation.  
The ability of the IVD to tolerate mechanical loads and provide stability to the 
spine depends a great deal on the integrity of the ECM. This requires a homeostasis 
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that balances the degradation of compromised macromolecules with the replacement 
of newly synthesized products (Buckwalter et al., 2005). Efficient turnover and 
remodeling of the matrix is accomplished by the action of matrix metalloproteinase 
(MMPs), a disintegrin and metalloproteinase with thrombospondin motifs 
(ADAMTS), and their regulators, the tissue inhibitor of metalloproteinases-1,2, and 3 
(TIMPs 1-3), produced by the cells of the IVD (Le Maitre et al., 2007). By affecting 
this balance, cells of the IVD are able to adaptively remodel matrix properties in 
response to mechanical demands (Adams et al., 1997). Perturbation of this 
equilibrium leads structural compromise and loss of disc hydration (Urban et al., 
2003). Consequently, the health of the disc is dependent on the ability of the cell to 
produce a matrix that is appropriate for the mechanical loads routinely encountered 
(Urban et al., 2000) 
Adequate nutrition and metabolite exchange of IVD cells has a profound effect on 
both the viability of the disc cells and their ability to produce ECM proteins (Horner 
et al., 2001). As oxygen supply is low in the avascular disc, the cells rely primarily on 
glycolysis and fermentation for energy, creating higher than physiologically optimal 
concentrations of lactate and thus a lower than optimal pH (Diamant et al., 1968). 
Although unfavorable, under normal conditions the discs are able to maintain a 
sufficient cell density that, while low in comparison to other tissues, is capable of 
meeting the minimum requirements to sustain viability (Stockwell et al., 1971). 
However, this mechanism is insufficient to support matrix upkeep when the disc is 
subjected additional stressors (Ohshima et al., 1992). This results in cell death in 
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response to either increased cell demand or a decrease in nutrient supply (Horner et 
al., 2001).  
As discs age, the permeability of the CEP is reduced compromising an already 
precarious exchange between the vertebral vessels and the IVD. The decreased 
permeability is the result of sclerosis, endplate chondrocyte apoptosis and 
calcification, the latter of which making the CEP completely impermeable 
(Nachemson et al., 1970). This has several deleterious effects on disc viability. The 
inability to efficiently remove glycolytic and fermentative byproducts, such as lactate, 
causes oxidative stress which leads to stress-induced premature senescence (Martin 
2004) and apoptosis (Sambrook et al., 1999), further compromising the IVD. As 
nutrient supply is reduced a state of low oxygen and pH leads to decreased 
proteoglycan synthesis by the remaining viable cells (Ishihara et al., 1999). Matrix 
degradation also results in the release of several soluble factors and inflammatory 
cytokines (Gruber et al., 1998). Inflammatory cytokines establish a positive feedback 
loop, inhibiting the production of ECM and stimulating the production of degradative 
enzymes (Moon et al., 2014). The failure to maintain the ECM is a significant 
contributor to disc desiccation (Walker et al., 2004) and consequently, IVDD. 
Along with nutritional stressors, mechanical stress also influences ECM 
maintenance and adaptation.  As previously mentioned compression of the IVD 
facilitate a mild degree fluid exchange, however this pressure also plays an important 
role in matrix turnover. Mild Compressive loads stimulate MMPs and nitric oxide to 
degrade the ECM in preparation for new synthesis, as well as stimulating matrix 
synthesis (Neidlinger-Wilke 2006), and appropriate long-term compressive loading 
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has been shown to increase PG content (Lotz et al., 1998) leading to improved disc 
hydration. Excessive prolonged over-loading however inhibits anabolic gene 
expression while over stimulating MMP production (Neidlinger-Wilke 2006). It is of 
interest to note that, while tenuous link between heavy physical work and 
occupational lifting and degeneration has been established (Heliovaara et al., 1989; 
Deyo et al., 1989; Pope et al., 2002), a study of elite athletes that spent a mean of 26 
years weightlifting with “maximal loads”, did not find a strong correlation with 
IVDD (Matsui et al., 1992), suggesting that perhaps the manner in which the weight 
is loaded, plays a larger role than the loading of weight itself.  
Torsional stress of the spine is primarily resisted by the apophyseal joint formed 
by the facets. The annulus can resist axial rotation of the individual vertebra up to 3 
degrees before collagen fibers begin to tear (Grignon et al., 2000). The facets restrict 
movement to 1.5 – 3 degrees, consequently damage can only occur from axial 
rotation when the spine is flexed, separating the apophyseal joint, and aggressively 
rotated (Adams et al., 1983). Damage from torsional rotation can present as either 
tears of the outer AF or as radial fissures emerging from the inner annulus (Aaro, 
1996). 
As degeneration progresses the NP experiences a reduction in both the size and 
number of PGs, resulting in the loss of adequate hydration. The strict organization of 
the NP and AF fibers also begins to become disorganized (Adams et al., 2006). This 
change is accompanied by transition of the NP consistency from gelatinous to more 
fibrous as cell phenotype shifts from chondrocyte-like to fibrocyte-like (Pattappa et 
al., 2012) and type II collagen is replaced with the denser type I collagen, which cross 
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link and hamper exchange of nutrients and waste (Shankar et al., 2009).  This shift 
substantially impedes the ability of the NP to hydrostatically distribute compressive 
loads across the CEP and the AF.  
Inappropriately distributed pressure causes the AF to crack and annular fissures 
begin to form. An annular fissure is a separation between annular fibers from their 
vertebral body insertions, or breaks through the fibers that extend through the 
concentric lamellae (Modic et al., 2007). Annular tears present in one of three 
categories, radial fissures, circumferential tears, and periphery tears (Figure 4) 
(Adams et al., 2004). Following injury, the IVD has a very limited capacity heal and 
sufficiently large tears must be replaced with granulation tissue, which lacks the 
tensile strength of collagen (McNally et al., 1992). 
Structural disruption of the disc or endplate always leads to cell-mediated 
degenerative changes (Adams et al., 2006). Small tears of the outer AF are adequately 
repaired by the mechanically inferior granulation tissue, the sparse cell population, 
however, is not sufficient to replace any structural compromise (Colombini et al., 
2008). The inflammatory cascade that follows disc injury recruits factors that induce 
matrix degradation, angiogenesis, and innervation (Moon et al., 2014).Annular 
fissures and neurovascular ingrowth into degenerative discs are a constant finding of 
histologic studies (Hunter et al., 2003). In the healthy IVD aggrecan inhibits 
endothelial growth (Johnson et al., 2002), thus as PG content declines in the 
degenerative disc, the loss of hydration is coupled to the loss of inhibition. Upon 
compromise of the superior aspect of the CEP, the CEP/AF interface, or of the outer 
annulus, the invasion of nerves and blood vessels results in addition deterioration of 
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IVD structural integrity and functionality. When the annulus is violated or scarred, 
the ability of the AF to contain the NP is drastically reduced (Bron et al., 2009), 
causing inappropriate pressure distribution throughout the annulus. Once the annulus 
is sufficiently compromised the rate progressive damage from inappropriate loading 
exceeds the rate of annular repair (Mengoni et al., 2015). Although increased 
vasculature supplies the deteriorating disc with increased nutrition, the coinciding 
structural compromise far exceeds the nutritional benefit. Thus injuries to the inner 
annulus or CEP that decompress the NP or moderate damage to the outer annulus 
leads to compounding damage and healing processes are over taken by degenerative 
changes (Hadjipavlou et al., 2008). 
1.3.2 Clinical Presentation and Identification 
 IVDD is most often observed in patients between the 4
th
 and 5
th
 decade of life, 
and may present clinically as lower back pain (LBP) or sciatica. These symptoms are 
commonly accompanied by a radiological finding of disc prolapse, spinal stenosis, 
facet joint arthropathy or a combination of each (Saleem et al., 2013). In the absence 
of imaging IVDD can be difficult to recognize, as there is a high prevalence of 
asymptomatic patients with radiological signs of degeneration (Jensen et al., 1994). 
When symptoms are present, they are often diverse and can range from the most 
common manifestation of pain, to debilitating neuropathy (Modic et al., 2007). 
 The cause of IVDD induced LBP is a subject of much debate, but there is 
evidence to suggest that, neural ingrowth, mechanical nerve compression, and 
inflammation are likely culprits. Nerves invading past the outer annulus form free 
nerve endings within the AF lamellae that are subsequently compressed with flexion 
  
14 
and extension of the spine (Brisby et al., 2006) and resulting in what is commonly 
referred to as discogenic pain. When the annulus is fully compromised the NP 
herniates into the spinal canal, termed a herniated nucleus pulposus (HNP) and may 
cause pain by directly compressing the spinal cord or dorsal root ganglia. This 
compression can result in unilateral or bilateral leg pain that radiates down the leg and 
into the feet or toes, and can cause numbness in the dermatomes corresponding to the 
compression, also known as sciatica (Saleem et al., 2013). However, while 90% of 
sciatica cases are associated with the presence of an HNP, as few as 30% of HNPs are 
symptomatic (Jordan et al., 2011). When nuclear material leaks out of the AF it has 
also been demonstrated to cause pain by inducing nerve degeneration, increasing 
nerve fiber discharge, and attracting inflammatory cells (Brisby et al., 2006). The 
inflammatory response has been suggested to sensitize nerve ending both in and 
around the IVD leading perception of pain with only mild stimulation (Goupille et al., 
1998). 
 Neuropathy also occurs with compression of the spinal nerves, presenting as 
peripheral neuropathy, myelopathy, or radiculopathy. Peripheral neuropathy 
associated with lumbar IVDD will often present as a “pins and needles” sensation or 
as tremor (Kashyap et al., 2004). When nerve compression is severe enough, muscle 
weakness can be observed as gait abnormalities or “foot drop”, the latter of which is 
characterized as an inhibition in dorsiflexion of the ankle or foot (Liu et al., 2013). 
Myelopathy and radiculopathy present in a similar fashion, both can result in, pain, 
muscle weakness, fasciculation and sensory deficits of the dermatomes innervated by 
the compressed nerves. However, myelopathy refers to the direct compression of the 
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spinal cord and tends to occur more gradually, where radiculopathy refers to the 
compression of the nerve root. As the spinal cord variably terminates between T12 
and L3 into the cauda equina, a collection of nerve roots, and most lumbar disc 
herniations occur between L4 and S1, radiculopathy is substantially more common in 
lumber herniations. 
 Disc prolapse, is a common findings in IVDD however there are additional signs 
of degeneration, consisting of diminished disc height, narrowing of facet, 
spondylophytes in the upper and lower endplates, stenosis of spinal canal, narrowing 
of lateral recess, real or apparent desiccation, fibrosis, extensive fissuring, mucinous 
degradation of annulus, defects and sclerosis of the end plates, osteophytes at the 
vertebral apophyses, loss of T2 signal, calcification vacuum changes, misalignment, 
and marrow changes (Nachemson et al., 1970) . As there are no definitive serum tests 
for biochemical markers of IVDD, the only ethically acceptable method of evaluating 
disc degeneration in a live population with a high degree of efficacy, is imaging (An 
et al., 2004). While X-rays can demonstrate osteophyte formation and CEP fractures, 
the preferred diagnostic tool for imaging and diagnosis of IVDD is magnetic 
resonance imaging (MRI) (Taher et al., 2012).  
 The radiographically observable alterations that occur during disc degeneration 
have been extensively described, but these changes must still be quantified for 
research purposes (Resnick et al., 1985). As many as 42 distinct grading systems for 
disc degeneration are described in literature, characterizing morphologic, histologic, 
and radiographic findings, most of which are based on subjective terminology (Lavy 
et al., 2010).  22 of these grading systems are specific to lumbar disc degeneration, 5 
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of which use MRIs. Of these five systems, only one, the Pfirrmann grading system, 
demonstrated substantial to almost perfect interobserver agreement (Lavy et al., 
2010). The Pfirrmann system relies on T2 signal intensity, distinction of NP and AF, 
and disc space narrowing to grade disc degeneration on a scale of I through V, with V 
being the most severely degenerated discs (Pfirrmann et al., 2001). T2 signal intensity 
is a function of proteoglycan content (Pearce et al., 1991) and thus correlates with the 
progression of IVDD (Modic et al., 1988). This system was associated with a small 
degree of ambiguity and furter modified in 2007 by Griffith et al. and presented as the 
modified Pfirrmann grading system (Table 1)  
Table 1. Modified Pfirrmann Grading System (Griffith et al. 2007) 
Grade 
Signal from nucleus and 
inner fibers of annulus 
Inner and outer 
annulus Height of disc 
1 Uniform Distinct Normal 
2 > Presacral Fat Distinct Normal 
3 < Presacral Fat Distinct Normal 
4 < Outer Fiber of Annulus Indistinct Normal 
5 = Outer Annulus Indistinct Normal 
6 = Outer Annulus Indistinct <30% Reduction 
7 = Outer Annulus Indistinct 30% to 60% Reduction 
8 = Outer Annulus Indistinct >60% Reduction 
 
 The most common disc disorder that presents to spinal surgeons is a lumbar HNP 
(Urban et al., 2003). Disc herniation is defined as a “localized or focal displacement 
of disc material beyond the limits of the intervertebral space” (Schroeder et al., 2016), 
with the disc space margins defined superiorly and inferiorly by the borders of each 
CEP and peripherally by the vertebral ring apophyses. HNPs can be sub divided into 
three categories, a protrusion which occurs when an intact AF bulges into the spinal 
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canal, an extrusion, when the contiguous NP violates the outer AF, and a 
sequestration, when the NP penetrates the AF and is no longer continuous, with a 
distinctly separate fragment (Spengler et al., 1990). The mechanical force necessary 
to induce an HNP in a healthy IVD is substantially greater than what is normally 
encountered, with most vertebral bodies failing before the IVD herniates in laboratory 
tests (Adams et al., 1982). Thus some degree of degeneration is necessary before a 
disc can herniate (Moore et al., 1996) in the absence of moderate trauma. 
1.3.3 Previous Studies and Genetic Influence 
  There is a substantial lack of epidemiological and population based data on disc 
degeneration (Hassett et al., 2003). Studies attempting to elucidate the environmental 
factors of IVDD are summarized well in a 1992 review, as focusing on gender, age, 
occupation, smoking and vehicular vibration (Frymoyer et al., 1992), with 
degeneration occurring primarily due to the accumulation of these factors in 
conjunction with mechanical injuries imposed on normal aging processes (Battie et 
al., 2004). However two decades later it is by and large believed that although there 
are certainly environmental elements, these factors seem to exert only minor effects 
on the development and progression of the disease when compared to genetic 
influences (Ala-kokko et al., 2002). Non-genetic risk factors still believed to 
exacerbate IVDD seem to be, an increased body mass index (BMI), age, diabetes, 
hyperlipidemia, mechanical insults, and smoking (Schroeder et al., 2016). One of the 
first major initiatives suggesting a genetic component to IVDD was the “Finnish 
Twin Study” which began in 1991. A cohort of 147 monozygotic and 153 dizygotic 
twins was recruited based on discordance of environmental and behavioral risk 
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factors believed to play a role at the time, and participated in a series of investigations 
(Battie et al., 2009). The studies found those twins heavily discordant for, driving, 
physical activity, leisure time, and physical loading, demonstrated almost no 
appreciable difference in disc degeneration, though cigarette smoking did seem to 
play a minor role (Battie et al., 2009). Most notable was a finding by Videman et al, 
demonstrating that lumbar disc degeneration had an almost 50% heritability 
(Videman et al., 2004).  
Genetic influences of IVDD have been of increasing interest since the publication 
of the Finnish twin findings; with recent studies suggest genetic factors can increase 
the risk of developing IVDD up to six times that of the general population (Chan et 
al., 2009).  
In over 20 years a myriad of studies have been conducted to try to determine a 
genetic component to IVDD. There are two common methods of studying genetic 
influences in IVDD, whole genome association studies (WGAS) and research 
directed investigation. WGAS involves sequencing the entire genome of pathological 
patients and control patients then comparing the frequency of alleles, variant 
mutations of the same gene, common to the pathological group with those of the 
control group. When an allele is found to occur at a statistically different frequency 
(Allele Frequency) to that of the control group it is considered associated with the 
pathology. This method casts a wide net, requires extensive analysis, and is generally 
costly, but can elucidate genes and pathways that were not previously suspected. 
Research directed investigations vary in methodology but follow three basic steps; 
identify pathology specific-genes through a literature review, select pathological 
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patients and control patients, then sequence patients for suspected genes. This method 
is fairly more elegant, with less data being analyzed and cost effective as only genes 
of interest are sequenced and investigated. 
 Most studies previously focused on determining IVDD candidate genes by 
examining associations of patients exhibiting signs of disc degeneration and 
mutations of exons affecting a single nucleotide, known as a single nucleotide 
polymorphism (SNP) (Videman et al., 2009). SNPs are alterations, as the name 
suggests, of a single nucleotide in a gene resulting in an alteration of the original 
sequence. A transition occurs when a purine (adenine [A] or guanine [G]) or a 
pyrimidine (cytosine [C] or thymine [T]) is replaced by a nucleotide of the same class 
(i.e. A to G or C to T). Transversions occur when a base is substituted with the base 
of a different class (i.e. C to G or A to T). An insertion or deletion occurs when a 
nucleotide is added or deleted and consequently alters the reading frame of the DNA, 
known as a frameshift. Frameshift mutations generally destroy the functionality of the 
translated protein. An SNP can result in three types of mutations; silent mutations, 
nonsense mutations, or missense mutations. A Silent mutation occurs when an 
alteration of a codon, the three nucleotide sequence that encodes an amino acid (AA), 
results in the production of an AA synonymous to that of the original codon. A 
nonsense mutation results in the altering of an AA codon to that of stop codon, 
resulting in a premature termination of translation. Finally a missense mutation is an 
alteration of a codon such that translation produces an AA that is not synonymous to 
the original codon.  
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These mutations can occur in exons, the expressed regions of a gene, introns, the 
intergenic regions, or in intergenic DNA. Introns are regions of DNA spaced between 
the exons, are removed prior to translation, and vary widely across individuals of the 
same species. Exons are the region of a gene that is ultimately converted to a mature 
mRNA. Exons contain a 5’ untranslated region (5’UTR), coding region (CDS), and a 
3’ untranslated region (3’UTR). The 5’ UTR plays a role in translation regulation, the 
CDS is the region that is translated into a protein, and the 3’UTR contains regulatory 
regions that function in post translational expression modification as well as stability 
and localization of the mRNA (Szostak et al., 2012). MicroRNA (MiRNA) are small 
noncoding RNA molecules that play a role in gene silencing. Most animal MiRNA 
binds to a region found in the 3’UTR (Wang et al., 122) and represent an additional 
form of 3’UTR posttranslational regulation. When a novel mutant allele is discovered 
it is reported to the database of SNPs (dbSNP) and assigned a Reference SNP cluster 
ID (rsNumber). 
Genes that have most often been implicated in IVDD are classified into one of 
three categories; genes involved with construction and structure of the IVD, genes 
that produce and regulate degrading enzymes, and genes associated with bone 
structure. Collagen, a major structural component of the IVD, has several SNPs 
commonly found in patients with IVDD (Plujim et al., 2004; Karppinen et al., 2002). 
Mutations in several inflammatory genes have also shown an association with IVDD 
(Solovieva et al., 2004; Noponen-Hietala et al., 2005) as well as the MMPs involved 
in matrix turnover and repair (Takahashi et al., 2001; Dong et al., 2007; Sun et al., 
2009; Hirose et al., 2008). The chief hydrating component of the NP, aggrecan 
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(Kawaguchi et al., 2008; Li et al., 2013), and the insulin-like growth factor receptor 
(IGF1) (Urano et al., 2008) are also implicated. Finally the vitamin D receptor (VDR) 
has been of interest in several genetic association studies (Kawaguchi et al., 2002; 
Cheung et al., 2006). 
1.4  Hypothesis 
  IVDD is a complex disease that is characterized by advanced signs of disc aging 
and is suggested to have a genetic component. An HNP in the absence of trauma 
represents a clear indication of disc degeneration. We hypothesize those young adults 
who have experienced an atraumatic lumbar HNP in the absence of common risk 
factors represent the ideal population for genetic analysis in an attempt to identify 
genetic components of IVDD. Further these patients with defects of structural or 
functional genes, when subjected to minor trauma or activation of an inflammatory 
cascade, will display early manifestation of IVDD. 
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Chapter 2 
Materials and Methods 
  All work in this section represents the efforts conducted by the graduate student. 
Work was conducted originally autonomously by the graduate student, then periodic 
meetings with the supervisor were held to confirm validity and applicability of the 
work. The work executed by the graduate student then periodically reviewed is 
referred to as work completed by “the graduate student”. Contributions of other 
bodies are referred to as “administrative staff” and include any efforts that were 
related to logistic support that was not directly connected to the investigation but was 
necessary to fulfill logistic or legal requirements and was carried out by hospital 
professional staff, or “SII”, which refers to the collective efforts of all individuals 
employed by System Imaginations Inc. who were involved in the project.  
2.1 Institutional Review Board Amendments 
An outdated Institutional Review Board (IRB) for Human Research application 
had previously been submitted. The IRB was modified by the graduate student to 
reflect the current aims of the study and submitted by hospital administrative staff. 
After revision the IRB was accepted and the investigation commenced. Three 
additional IRB amendments were made through the course of the study to 
accommodate a change from exome sequencing to whole genome sequencing, an 
increase in the volume of blood to be drawn and the inclusion of patients under the 
age of 18 in the study. 
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2.2 Gene Selection 
An exhaustive literature review was conducted be the graduate student to select 
genes for investigation (Urban et al., 2003; Hadjipavlou et al., 2008; Colobini et al., 
2008; Videman et al., 2004; Battie et al., 2009; Chan et al., 2006; Videman et al., 
2009; Plujim et al., 2004; Karppinen et al., 2002; Solovieva et al., 2004; Takahashi et 
al., 2001; Dong et al., 2007; Sun et al., 2009; Hirose et al., 2008; Kawaguchi et al., 
1999; Urano et al., 2008; Noponen-Hietala et al., 2005; Kawaguchi et al., 2002; 
Cheung et al., 2002; Roughley et al., 2006; Aigner et al., 1998; Roberts et al., 1998; 
Tilkeridis et al., 2005; Paassilta et al., 2001; Futoshi et al., 2007, Zhang et al., 2008; 
Kalichman et al., 2008; Mayer et al., 2013; Eskola et al., 2012; Betram et al., 2006; 
Chen et al., 2013; Han et al., 2013; Gologorsky et al., 2014; Cheung et al., 2010; 
Nerlich et al., 2005). Genes were investigated based on potential association with 
IVD structural components and inflammatory pathways. Genes were selected based 
on representation in literature and level of previous investigation. After review 
COL1A1, COL9A2, COL9A3, COL11A1, COL11A2, IGF1R, ACAN, IL1, IL6R, 
MMP2, MMP3, MMP9, THBS2 and VDR were selected further investigation in the 
study.  
2.3 Patient Selection 
All subjects were selected by the graduate student from a list of patients who had 
undergone a microdiscectomy surgical resection at the Phoenix St. Joseph’s branch of 
the Barrow Neurological Institute (BNI). The patients had a positive diagnosis of 
lumbar disc herniation both pre and post operatively and were graded above grade II 
on the Pfirrmann grading scale. The mean age of patients at time of surgery was 25 
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years, with a mean time of 2.3 months between radiological diagnosis and surgery. 10 
Patients self-identified as Caucasian/White, 4 as Hispanic/Latino, and 1 as African 
American. 6 patients had a single herniation between L5-S1, 5 Patients had a single 
herniation between L4-L5, 3 patients had three herniations between L3-S1, and 1 
patient had two herniations between L3-L5.  
2.3.1 Inclusion Criteria  
An extensive literature review was conducted by the graduate student for risk 
factors that have been associated with IVDD (Roughley et al., 2006; Hadjipavlou et 
al., 2008; Aigner  et al., 1998; Hassett et al., 2003, Roberts et al., 1998; Videman et 
al., 2004; Shankar et al., 2009; Raj, 2008, Battie et al., 2009; Schroeder et al., 2016; 
Adams et al., 2006; Modic et al., 2007), and inclusion criteria were determined. 
Patients must have undergone a microdiscectomy at BNI and received both a 
radiological diagnosis and operative diagnosis of lumbar HNP, and have grade II 
degeneration upon BNI review of MRIs to be considered. Only patients diagnosed 
with a lumbar HNP under the age of 30 were considered. Only patients that 
experienced HNP with no or minor trauma, defined as “greater than a sneeze, but less 
than a fall” where were considered. 
2.3.2 Exclusion criteria 
Exclusion criteria were determined by the graduate student based on the literature 
review conducted in section 2.3.1. Any patient that presented with an HNP 
immediately following a trauma, defined as “Any physical insult that would exceed 
that experienced on a daily basis”, or any patient that experienced back pain within 1 
year of trauma was excluded. All patients who participated in club or school, 
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baseball, swimming, basketball, kendo/martial arts, soccer, or football after 
graduating high school were excluded. Patients that had a BMI of over 30 and were 
classified as endomorphic or diagnosed with hyperlipidemia were excluded. Patients 
that worked jobs that required unsupervised heavy physical lifting (warehouse 
workers, furniture movers, construction workers etc.) or described their employment 
as “requiring sporadic physical exertion” were excluded. Any patient that experienced 
more than 10 hours of driving a week was excluded. Patients who smoked more than 
1 pack year, defined as the product of the number of packs of cigarettes smoked per 
day and the number of years the patient has smoked, were excluded.  
2.3.3 Final Patient Selection 
1,005 patients presented between 2006 and 2015 with lumbar HNPs that were 
treated with microdiscectomy. The graduate student determined that 66 patients 
fulfilled all inclusion requirements, 23 of which were removed for presence of 
exclusion criteria. The 43 remaining patients were contacted by the graduate student 
and asked to participate, 39 agreed. Phone interviews were then conducted by the 
graduate student with the patients to confirm accuracy of inclusion and exclusion 
criteria, at which point 2 patients were excluded. After a second thorough review of 
the patient information, all 37 patients were approved by administrative staff for the 
study. Of these 37, 17 patients were able to participate in the study due to various 
working or personal constraints.  
2.4 Collection Preparation  
A third party bioinformatics company, System Imaginations Inc. (SII) was 
recruited to assist in identification of logistic needs for the study and for analytic 
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support in future studies. The graduate student working with SII determined that 
DNA would be collected from blood and saliva samples, protein samples would be 
collected from blood, and RNA would be collected from blood. Due to a shift in 
sequencing cost the graduate student and SII determined that whole genome 
sequencing was fiscally feasible and would be superior to exome sequencing. Various 
collection vessels were researched and debated between SII and the graduate student. 
EDTA vacutainers were determined to be the best option for DNA collection and 
storage of blood specimens (Banfi et al., 2007) per the graduate student, and Oragene 
Discover tubes were selected for saliva samples per SII suggestion. PAX Gene tubes 
were selected for collection of RNA blood samples per agreement of efficacy 
between SII and the graduate student. The P100 Blood Collection System (P100BCS) 
was selected for blood protein sample collection per agreement of efficacy between 
SII and the graduate student. Subjective patient data was desired for future studies 
and an SF36, Visual Analog Scale (VAS), and Oswestry Disability Index 
questionnaire were selected to collect this information per the graduate student. 
Morphological data was implicated in future studies and a 34 point measurement 
system was developed through coordination of SII personnel and the graduate student 
to account for potential future needs. Due to conflicting schedules and time 
constraints 17 of the 37 approved patients were able to participate in the study and 
were scheduled by administrative staff for study collections, however 2 sample were 
not used due to study timeline incompatibilities. 
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2.5 Sample Collection 
Approved patients participating in study arrived at BNI and provided informed 
consent via the graduate student and administrative staff. Patients were vetted a third 
time for any exclusion criteria, no patients were excluded at this stage. Morphological 
information was collect in accordance with the developed 34 point system on each 
patient. Patients were taken to the clinical laboratory in the St. Joseph Medical Center 
and lab personnel extracted samples that were processed by the graduate student. 
Salvia samples were collected in Oragene tubes through oral sputum throughout the 
duration of the visit, when a sufficient sample was collected the tube was sealed, 
homogenized though inversion for 5 second, placed in a freezer with a holding 
temperature of -20 degrees Celsius (“the -20”) for 24 hours, then transferred to a 
freezer with a holding temperature of -80 degrees Celsius (“the -80”). 3ml of blood 
was collected in EDTA Vacutainers, homogenized via inversion ten times, and then 
placed in the -80 for storage. 8.5 ml of blood was collected in P100BCS tubes, 
homogenized through inversion 10 times, allowed to incubated at room temperature 
for 2 – 4 hours, centrifuged at 2500g for 20 minutes, plasma supernatant was 
extracted and placed in cryovials which were placed in the -20 for 24 hours, then 
moved to the -80 for storage. 2.5ml of blood was collected in PAXgene tubes, 
homogenized through inversion 10 times, incubated at room temperature for 2 hours, 
placed in the -20 for 24 hours, and then moved to the -80 for storage. Upon collection 
of final specimens SII took procession of EDTA samples and handled the subsequent 
shipping and transport to Macrogen Clinical Labs for sequencing. All other samples 
were stored in the -80 for future studies. Protein, RNA and morphological data were 
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not used in the current study but were determined by the graduate student and SII to 
be of potential value in future studies. 
2.6 Annotation and Data Storage  
SII was chosen to annotate the sequenced data and store the electronic 
information. SII developed a graphic user interface, the “Spondylo Viewer”, for 
querying of patients vs. genes with mutations allowing for searches yielding patients 
with mutations of suspected genes. SII vetted and selected Macrogen Clinical Labs to 
perform DNA extraction from EDTA stored sample for DNA QC, library prep and 
DNA sequencing. Upon completion of DNA sequencing, raw data was uploaded to 
the Spondylo Viewer. DNA integrity and quality was assessed by SII and determined 
to be of “excellent quality” and no samples were excluded. 
2.7 Data Analysis 
The American and European subset of The 1000 Genomes Project was selected as the 
optimal reference genome, as a more diverse population was included than in alternate 
references such as the GR37 or HG19, and the 2010 pilot paper was one of the most cited 
articles in biology in 2011 (Science Watch, 2012). The graduate student used the 
Spondylo Viewer to search selected genes for mutations, defined as an alteration from the 
reference genomes. Transition, transversion, insertion, and deletion locations were noted 
and mutation effects were determined by comparing alterations against the relevant 
reference. Mutation effect, nucleotide alteration, resulting AA change, distance of 
mutation from beginning of gene, allele frequency, and novelty, were determined and 
recorded by the graduate student, haplotype was supplied by SII. Mutations of interest 
were investigated and resulting protein alterations were characterized. A Chi Square test 
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was applied to determine the statistical relevance of findings. Observed frequencies from 
the study and expected frequencies supplied by the American subset of the 1000 
Genomes Project were used in analysis. Due to the notably small sample size it was 
determined that a p value of 0.05 would be inappropriate and the more stringent p value 
of 0.005 was applied (Kenny et al., 2002).  
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Chapter 3 
Results and Interpretation 
Table 2. Abbreviations used in result tables. 
Mut Effect Type of mutation 
Ref to Alt Nucleotide change from reference genome  
AA Change Amino acid change 
Mut Pos Position from first nucleotide where mutation occurs 
AF Allele frequency (UKN = Unknown) 
RSN Reference SNP cluster ID reported to dbSNP 
Haplo Haplotype (Homo = Homozygous Hetero = Heterozygous) 
3.1 Collagen  
3.1.1 Collagen 1 Alpha subunit 1  
 The variant rs112626388 was found in 86.66% of patients, which is above the expected 
frequency of 69% ( p < 0.005). This variant is in the 3’UTR. One patient, 6.6%, 
expressed the rare variant rs72667032, the expected frequency is 0.43% ( p < 0.005). This 
variant occurs in the triple helix repeat, and is a shift from one hydrophobic AA to 
another. A novel 3’ UTR deletion variant was found at position 1040 in 6.6% of patients. 
Table 3. COL1A1 Variants 
Patient 
Mut 
Effect Ref to Alt 
AA 
Change Mut Pos AF RSN Haplo 
P_192 Insertion G to GTG 3’ UTR 681/682 0.69 rs112626388 Hetero 
P_196 Insertion G to GTG 3’ UTR 681/682 0.69 rs112626388 Hetero 
P_262 Insertion G to GTG 3’ UTR 681/682 0.69 rs112626388 Hetero 
P_262 Missense C to G P to A 613 0.004 rs72667032 Hetero 
P_419 Insertion G to GTG 3’ UTR 681/682 0.69 rs112626388 Hetero 
P_445 Deletion GA to G 3’ UTR 1040 UKN Novel Hetero 
P_531 Insertion G to GTG 3’ UTR 681/682 0.69 rs112626388 Hetero 
P_562 Insertion G to GTG 3’ UTR 681/682 0.69 rs112626388 Hetero 
P_654 Insertion G to GTG 3’ UTR 681/682 0.69 rs112626388 Hetero 
P_659 Insertion G to GTG 3’ UTR 681/682 0.69 rs112626388 Hetero 
P_692 Insertion G to GTG 3’ UTR 681/682 0.69 rs112626388 Hetero 
P_725 Insertion G to GTG 3’ UTR 681/682 0.69 rs112626388 Hetero 
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P_752 Insertion G to GTG 3’ UTR 681/682 0.69 rs112626388 Hetero 
P_832 Insertion G to GTG 3’ UTR 681/682 0.69 rs112626388 Hetero 
P_942 Insertion G to GTG 3’ UTR 681/682 0.69 rs112626388 Hetero 
 
3.1.2 Collagen 9 Alpha Subunit 2 
The rare variant rs140041506 appeared in 13.3% of patients, with an expected frequency 
of only 1% ( p < 0.005). This variation occurs in the triple helix region and represents a 
shift from a hydrophobic residue to a hydrophilic residue. 
Table 4 COL9A2 Variants 
Patient Mut Effect 
Ref to 
Alt AA Change 
Mut 
Pos AF RSN Haplo 
P_562 Missense G to T P to T 1981 0.01 rs140041506 Hetero 
P_692 Missense G to T P to T 1981 0.01 rs140041506 Hetero 
  
3.1.3 Collagen 9 Alpha Subunit 3 
 The rare variant rs61734651 was found in 20.0% of patients, with an expected 
frequency of only 2.7% ( p < 0.005). This mutation occurs in the triple helix domain and 
is the shift from a basic residue to a nonpolar residue. A novel variant was found at 
position 1625 in 6.6% of patients; this mutation is in the triple helix domain and is the 
transition from one hydrophobic AA to another. 
Table 5 COL9A3 Variants  
Patient 
Mut 
Effect 
Ref to 
Alt AA Change 
Mut 
Pos AF RSN Haplo 
P_262 Missense C to G A to G 1625 UKN Novel Hetero 
P_419 Missense C to T R to W 307 0.027 rs61734651 Hetero 
P_659 Missense C to T R to W 307 0.027 rs61734651 Hetero 
P_832 Missense C to T R to W 307 0.027 rs61734651 Hetero 
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3.1.4 Collagen 11 Alpha Subunit 1 
The variant rs3753841 was found in 80% of patients with an expected frequency of 
75.5% ( p > 0.005). This variant is in the triple helix region; all patients with this allele 
were homozygous. The rare variants rs140954784 and rs144562769 were expressed in 
one patient, 6.6%, with an expected frequency of 0.005% ( p < 0.005)  and 0.002% ( p 
< 0.005)  respectively; both reside in the triple helix domain with the former being a 
change between two hydrophobic residues, and the latter a shift from a hydrophobic 
residue to a hydrophilic one. The variant rs36076089 was found in 20% of patients with 
an expected frequency of 1% ( p < 0.005). This variant is found in the splice region and 
is not part of the splice site palindrome. The extremely rare variant rs143875783 was 
found in 6.6% of patients, with an expected frequency of 0.0% ( p < 0.005). This 
variant is found in the 3’ UTR. 
Table 6 COL11A1 Variants  
Patient Mut Effect 
Ref to 
Alt 
AA 
Change 
Mut 
Pos AF RSN Haplo 
P_192 Missense C to T  P to L 3851 0.755 rs3753841 Homo 
P_196 Missense C to G P to A 4477 0.0005 rs140954784 Hetero 
P_196 Missense C to A P to T 3112 0.0002 rs144562769 Hetero 
P_262 Missense C to T P to L 3851 0.755 rs3753841 Homo 
P_419 Splice GA to G SRV 652     0.01 rs36076089 Hetero 
P_419 Missense C to T P to L 3851 0.755 rs3753841 Homo 
P_531 Missense C to T P to L 3851 0.755 rs3753841 Homo 
P_562 Missense C to T P to L 3851 0.755 rs3753841 Homo 
P_654 Missense C to T P to L 3851 0.755 rs3753841 Homo 
P_659 Transition G to A 3' UTR 809 0.000 rs143875783 Hetero 
P_659 Missense C to T P to L 3851 0.755 rs3753841 Homo 
P_692 Missense C to T P to L 3851 0.755 rs3753841 Homo 
P_725 Missense C to T P to L 3851 0.755 rs3753841 Homo 
P_752 Splice GA to G SRV 652     0.01 rs36076089 Hetero 
P_752 Missense C to T P to L 3851 0.755 rs3753841 Homo 
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P_832 Missense C to T P to L 3851 0.755 rs3753841 Homo 
P_942 Splice GA to G SRV 652     0.01 rs36076089 Hetero 
P_942 Missense C to T P to L 3851 0.755 rs3753841 Homo 
  
3.1.5 Collagen 11 Alpha Subunit 2 
The rare variant rs2229784 was present in 13.3% of patients, with an expected frequency 
of 4% ( p < 0.005). This mutation is in the triple helix region and is a shift from a 
hydrophobic residue to a hydrophilic residue. 
Table 7 COL11A2 Variants 
Patient Mut Effect Ref to Alt AA Change Mut Pos AF RSN Haplo 
P_562 Missense G to T P to T 3625 0.05 rs2229784 Hetero 
P_659 Missense G to T P to T 3625 0.05 rs2229784 Hetero 
 
3.2 Interleukins 
3.2.1 Interleukin 1 Alpha 
 No IL1A variants were found in the patients. 
3.2.2 Interleukin 6 Receptor    
  The common variant rs2228145 was found in 46.6% of patients with an expected 
frequency of 53% ( p > 0.005). This variant occurs in the fibronectin type III domain. All 
patients were homozygous for this allele. 
Table 8 IL6R Variants 
Patient 
Mut 
Affect Ref to Alt AA Change AA Pos AF RSN Haplo 
P_196 Missense A to C D to A 1073 0.53 rs2228145 Homo 
P_445 Missense A to C D to A 1073 0.53 rs2228145 Homo 
P_562 Missense A to C D to A 1073 0.53 rs2228145 Homo 
P_654 Missense A to C D to A 1073 0.53 rs2228145 Homo 
P_659 Missense A to C D to A 1073 0.53 rs2228145 Homo 
P_725 Missense A to C D to A 1073 0.53 rs2228145 Homo 
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P_832 Missense A to C D to A 1073 0.53 rs2228145 Homo 
  
3.3 Vitamin D Receptor 
  The Variant rs371312471 and a novel variant at 2102 were both found in two 
patients. These mutations were 1 nucleotide apart in the 3’ UTR. The rare variant rs9729 
was found in 1 patient constituting a frequency of 6.6% with an expected value of 0.06% 
( p < 0.005). This mutation was found in the 3’ UTR. 
Table 9 VDR Variants 
Patient Mut Effect 
Ref to 
Alt 
NT 
Change 
Mut 
Pos AF RSN Haplo 
P_419 Transversion A to T 2100 3’UTR  UKN Novel Hetero 
P_419 Transversion G to T 2102 3’UTR  UKN rs371312471 Hetero 
P_445 Transversion A to T 2100 3’UTR  UKN Novel Hetero 
P_445 Transversion G to T 2102 3’UTR  UKN rs371312471 Hetero 
P_692 Transversion C to G 1906 3’UTR  0.006 rs9729 Hetero 
  
3.4 Insulin-like Growth Factor 1 Receptor 
All IGF1R variants were found in the 3’ UTR. The common insertion rs3051367 
was found in 66% of patients with an expected frequency of 44% ( p < 0.005). The fairly 
common variant rs35715134 was found in 93% of patients and expected in 49% ( p < 
0.005). The deletion rs58523117 common to the American population was found in 93% 
of patients and expected in 85% ( p > 0.005). Variant rs375097523 was expressed in 
6.6% of patients and has previously been reported, but no population data is available. 
Mutation rs3051365 was found in 13% of patients with a population frequency of 1% ( p 
< 0.005). 1 Patient expressed rs3833014 representing 6.6%% to an expected 8% ( p > 
0.005)  of the cohort. 4 novel variants were discovered; a transversion at position 2291, a 
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deletion at 5771, a transition at 3603, and an insertion at 5741. All patients were 
heterozygous for variants. 
Table 10 IGF1R Variants 
Patient 
Mut 
Effect Ref to Alt 
AA 
Change Mut Pos AF RSN Haplo 
P_192 Insertion C to CTT 3' UTR 2851/2852  0.44 3051367 Hetero 
P_192 Deletion GA to G 3' UTR 1259  0.49 35715134 Hetero 
P_192 Deletion GGT to  G 3' UTR 2529/2530  0.86 58523117 Hetero 
P_192 Insertion C to CAT 3' UTR 1753/1754  0.01 3051365 Hetero 
P_196 Deletion GGT to G 3' UTR 2529/2530  0.86 58523117 Hetero 
P_196 Deletion GA to G 3' UTR 1259  0.49 35715134 Hetero 
P_196 Insertion C to CTT 3' UTR 2851/2852  0.44 3051367 Hetero 
P_262 Transition G to A 3' UTR 3443  UKN 375097523 Hetero 
P_262 Deletion GGT to G 3' UTR 2529/2530  0.86 58523117 Hetero 
P_419 Deletion GA to G 3' UTR 1259  0.49 35715134 Hetero 
P_419 Deletion GGT to G 3' UTR 2529/2530  0.86 58523117 Hetero 
P_445 Deletion GGT to G 3' UTR 2529/2530  0.86 58523117 Hetero 
P_445 Deletion GA to G 3' UTR 1259  0.49 35715134 Hetero 
P_531 Transvers C to A 3' UTR 2291  UKN Novel Hetero 
P_531 Insertion G to GC 3' UTR 3465  0.08 3833014 Hetero 
P_531 Insertion C to CTT 3' UTR 2851/2852  0.44 3051367 Hetero 
P_531 Deletion GGT to G 3' UTR 2529/2530  0.86 58523117 Hetero 
P_531 Deletion GA to G 3' UTR 1259  0.49 35715134 Hetero 
P_531 Deletion CA to C 3' UTR 5771  UKN Novel Hetero 
P_562 Deletion GA to G 3' UTR 1259  0.49 35715134 Hetero 
P_562 Insertion T to TC 3' UTR 5741  UKN Novel Hetero 
P_624 Deletion GGT to G 3' UTR 2529/2530  0.86 58523117 Hetero 
P_624 Insertion C to CTT 3' UTR 2851/2852  0.44 3051367 Hetero 
P_624 Deletion GA to G 3' UTR 1259  0.49 35715134 Hetero 
P_654 Deletion GGT to G 3' UTR 2529/2530  0.86 58523117 Hetero 
P_654 Insertion C to CTT 3' UTR 2851/2852  0.44 3051367 Hetero 
P_654 Deletion GA to G 3' UTR 1259  0.49 35715134 Hetero 
P_659 Insertion C to CTT 3' UTR 2851/2852  0.44 3051367 Hetero 
P_659 Deletion GGT to G 3' UTR 2529/2530  0.86 58523117 Hetero 
P_659 Deletion GA to G 3' UTR 1259  0.49 35715134 Hetero 
P_692 Insertion C to CTT 3' UTR 2851/2852  0.44 3051367 Hetero 
P_692 Insertion C to CAT 3' UTR 1753/1754  0.01 3051365 Hetero 
P_692 Deletion GGT to G 3' UTR 2529/2530  0.86 58523117 Hetero 
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P_692 Deletion GA to G 3' UTR 1259  0.49 35715134 Hetero 
P_725 Insertion C to CTT 3' UTR 2851/2852  0.44 3051367 Hetero 
P_725 Transition G to A 3' UTR 3603  UKN Novel Hetero 
P_725 Deletion GGT to G 3' UTR 2529/2530  0.86 58523117 Hetero 
P_725 Deletion GA to G 3' UTR 1259  0.49 35715134 Hetero 
P_752 Insertion C to CTT 3' UTR 2851/2852  0.44 3051367 Hetero 
P_752 Deletion GGT to G 3' UTR 2529/2530  0.86 58523117 Hetero 
P_752 Deletion GA to G 3' UTR 1259  0.49 35715134 Hetero 
P_832 Deletion GGT to G 3' UTR 2529/2530  0.86 58523117 Hetero 
P_832 Deletion GA to G 3' UTR 1259  0.49 35715134 Hetero 
P_832 Insertion C to CTT 3' UTR 2851/2852  0.44 3051367 Hetero 
P_942 Deletion GGT to G 3' UTR 2529/2530  0.86 58523117 Hetero 
P_942 Deletion GA to G 3' UTR 1259  0.49 35715134 Hetero 
 
3.5 Aggrecan 
The variant rs35430524 was found in 1 patient making up 7% of an expected 15% ( p > 
0.005)  of the study group. This variant effects the chondroitin sulfate I (CS-I) domain, 
replacing a hydrophobic AA with a polar residue. The variant rs12899191 was previously 
recorded but no population data is available, this allele was found in 67% of patients. The 
variant represent a shift from a polar to a non-polar AA and occurring in the CS-I 
domain. The uncommon allele rs938608 was found in 73% of patients with an expected 
frequency of 40% ( p < 0.005). This mutation is a change from a polar to a non-polar 
residue and occurs in the CS-I region. The common allele rs3817428 was present in 47% 
of patients while expected in 87% ( p < 0.005). This is a switch between two acidic AAs 
and is present in globular structural domain 3 (G3). The uncommon allele rs2882676 was 
displayed in 67% of patients with an expected frequency of 38% ( p < 0.005). This 
mutation is a change from an acidic polar AA to a hydrophobic AA. Rs2882676 affects 
the chondroitin sulfate II (CS-II) domain. The uncommon allele rs938609 was present in 
73% of patients and has a frequency of 38% ( p < 0.005). This variant interchanges 
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between two polar residues, and resides in the CS-I domain. The rare allele rs117116488 
was present in 13% of patients with an expected frequency of 0.5% ( p < 0.005). This 
variant changes a polar residue to a non-polar residue. This variant is in the globular 
structural domain II B (G2B). The rare allele rs28559926 was found in 20% of patients 
with a population frequency of 5% ( p < 0.005). This mutation results in an exchange 
between two acidic AAs, and is part of the CS-I domain. The uncommon variant 
rs3743398 was represented in 33% of patients and expected in 11% ( p < 0.005). This 
variant changes between two nonpolar residues, and effects the CS-I region. The rare 
variant rs181736584 was found in 13% of patients and expected in 0.1% ( p < 0.005). 
This is an alteration between two nonpolar bases and is part of the aggrecan core protein. 
The uncommon allele rs35546357 was present in 1 patient constituting 6.6%% of patients 
and was expect to account for 2% ( p > 0.005). This variant is an alteration between a 
polar and nonpolar residue, and is in the CS-I domain. The common variant rs11638262 
was expressed in 6.6%% of the cohort, and expected in 49% ( p < 0.005). This mutation 
is a shift from a hydrophobic to a hydrophilic AA, and is in the CS-I domain. 
Table 11 ACAN Variants 
Patient 
Mut 
Effect Ref to Alt 
AA 
Change 
Mut 
Pos AF RSN Haplo 
P_192 Missense C to A P to T 2737 0.15 rs35430524 Hetero 
P_192 Missense A to G T to A 4207 UKN rs12899191 Hetero 
P_196 Missense G to T S to I 2789 0.40 rs938608 Hetero 
P_196 Missense C to G D to E 7005 0.87 rs3817428 Hetero 
P_196 Missense A to C E to A 4523 0.38 rs2882676 Hetero 
P_196 Missense T to A S to T 2815 0.38 rs938609 Hetero 
P_196 Missense C to T S to L 1469 0.005 rs117116488 Hetero 
P_196 Missense A to G T to A 4207 UKN rs12899191 Hetero 
P_196 Missense G to C E to D 4227 0.05 rs28559926 Hetero 
P_196 Missense C to T P to L 2591 0.11 rs3743398 Hetero 
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P_262 Missense C to T P to L 2591 0.11 rs3743398 Hetero 
P_262 Missense A to G T to A 4207 UKN rs12899191 Hetero 
P_262 Missense C to G D to E 7005 0.87 rs3817428 Hetero 
P_262 Missense A to C E to A 4523 0.38 rs2882676 Hetero 
P_262 Missense G to T S to I 2789 0.40 rs938608 Hetero 
P_262 Missense T to A S to T 2815 0.38 rs938609 Hetero 
P_262 Missense C to G D to E 7005 0.87 rs3817428 Hetero 
P_419 Missense C to T P to L 2591 0.11 rs3743398 Hetero 
P_419 Missense C to G D to E 7005 0.87 rs3817428 Hetero 
P_419 Missense T to A S to T 2815 0.38 rs938609 Hetero 
P_419 Missense G to T S to I 2789 0.40 rs938608 Hetero 
P_419 Missense A to C E to A 4523 0.38 rs2882676 Hetero 
P_419 Missense T toC F to L 1366 0.001 rs181736584 Hetero 
P_419 Missense A to G T to A 4207 UKN rs12899191 Hetero 
P_445 Missense G to C E to D 4227 0.05 rs28559926 Hetero 
P_531 Missense G to T S to I 2789 0.40 rs938608 Hetero 
P_531 Missense A to G T to A 4264 0.02 rs35546357 Hetero 
P_531 Missense A to G T to A 4207 UKN rs12899191 Hetero 
P_531 Missense T to A S to T 2815 0.38 rs938609 Hetero 
P_562 Missense A to G T to A 4207 UKN rs12899191 Hetero 
P_624 Missense A to C E to A 4523 0.38 rs2882676 Hetero 
P_624 Missense G to T S to I 2789 0.40 rs938608 Hetero 
P_624 Missense A to G T to A 4207 UKN rs12899191 Hetero 
P_624 Missense T to A S to T 2815 0.38 rs938609 Hetero 
P_654 Missense T to A S to T 2815 0.38 rs938609 Hetero 
P_654 Missense G to T S to I 2789 0.40 rs938608 Hetero 
P_654 Missense T toC F to L 1366 0.001 rs181736584 Hetero 
P_654 Missense A to C E to A 4523 0.38 rs2882676 Hetero 
P_654 Missense C to G D to E 7005 0.87 rs3817428 Hetero 
P_659 Missense A to G T to A 4207 UKN rs12899191 Hetero 
P_659 Missense A to C E to A 4523 0.38 rs2882676 Hetero 
P_659 Missense G to T S to I 2789 0.40 rs938608 Hetero 
P_659 Missense T to A S to T 2815 0.38 rs938609 Hetero 
P_692 Missense G to T S to I 2789 0.40 rs938608 Hetero 
P_692 Missense T to A S to T 2815 0.38 rs938609 Hetero 
P_692 Missense G to A A to T 3637 0.49 rs11638262 Hetero 
P_692 Missense A to C E to A 4523 0.38 rs2882676 Hetero 
P_725 Missense C to T P to L 2591 0.11 rs3743398 Hetero 
P_725 Missense G to T S to I 2789 0.40 rs938608 Hetero 
P_725 Missense T to A S to T 2815 0.38 rs938609 Hetero 
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P_725 Missense A to G T to A 4207 UKN rs12899191 Hetero 
P_725 Missense A to C E to A 4523 0.38 rs2882676 Hetero 
P_752 Missense C to G D to E 7005 0.87 rs3817428 Hetero 
P_752 Missense T to A S to T 2815 0.38 rs938609 Hetero 
P_752 Missense G to T S to I 2789 0.40 rs938608 Hetero 
P_752 Missense A to C E to A 4523 0.38 rs2882676 Hetero 
P_752 Missense A to G T to A 4207 UKN rs12899191 Hetero 
P_832 Missense G to C E to D 4227 0.05 rs28559926 Hetero 
P_832 Missense C to T S to L 1469 0.005 rs117116488 Hetero 
P_942 Missense A to C E to A 4523 0.38 rs2882676 Hetero 
P_942 Missense G to T S to I 2789 0.40 rs938608 Hetero 
P_942 Missense C to G D to E 7005 0.87 rs3817428 Hetero 
P_942 Missense C to T P to L 2591 0.11 rs3743398 Hetero 
P_942 Missense T to A S to T 2815 0.38 rs938609 Hetero 
  
3.6 Matrix Remodeling Enzymes 
3.6.1 Matrix Metalloproteinase -2  
 No patients presented variants of MMP2. 
3.6.2 Matrix Metalloproteinase- 3  
73% of patients expressed the common allele variant rs679620, with an expected 
frequency of 68% ( p > 0.005). This mutation was in the peptidoglycan binding region 
and resulted in a basic residue being replaced by an acidic residue. 
Table 12 MMP3 Variants 
Patient 
Mut 
Effect 
Ref to 
Alt 
AA 
Change 
Mut 
Pos AF RSN Zygosity 
P_192 Missense A to G K to E 133 0.68 rs679620 Hetero 
P_196 Missense A to G K to E 133 0.68 rs679620 Hetero 
P_262 Missense A to G K to E 133 0.68 rs679620 Hetero 
P_419 Missense A to G K to E 133 0.68 rs679620 Hetero 
P_445 Missense A to G K to E 133 0.68 rs679620 Hetero 
P_531 Missense A to G K to E 133 0.68 rs679620 Hetero 
P_624 Missense A to G K to E 133 0.68 rs679620 Hetero 
P_659 Missense A to G K to E 133 0.68 rs679620 Hetero 
P_692 Missense A to G K to E 133 0.68 rs679620 Hetero 
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P_832 Missense A to G K to E 133 0.68 rs679620 Hetero 
P_942 Missense A to G K to E 133 0.68 rs679620 Hetero 
   
3.6.3 Matrix Metalloproteinase- 9 
 No patients were found to have variants in the MMP9 gene. 
3.6.4 Thrombospondin 2 
 The rare variant rs151019608 was found in 13.3% of patients against an expected 
frequency of 3% ( p < 0.005). This mutation is found in the 3’ UTR. A novel mutation 
was found in 1 patient who also had the rs151019608 variant. The mutation was at 
nucleotide 3355 and is in the Concanavalin A-like lectin/glucanase domain. A second 
novel variant was found in 1 patient at nucleotide 761, in the 3’ UTR. 
Table 13 THBS2 Variants 
Patient 
Mut 
Effect Ref to Alt 
AA 
Change Mut Pos AF RSN Haplo 
P_752 Missense T to C K to E 3355 ukn Novel Hetero 
P_262 Transvers T to G 3' UTR 761 ukn Novel Hetero 
P_659 Deletion CTAA to C 3' UTR 1139/1141  0.03 151019608 Hetero 
P_752 Deletion CTAA to C 3' UTR 1139/1141  0.03 151019608 Hetero 
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Chapter 4  
Discussion, Future Studies, and Conclusion   
4.1 Collagen Findings 
 Collagen is the chief component of the AF and is an obvious target for research 
into IVDD. COL1A1 is primarily found in the outer annulus and was the first gene to 
be investigated, and no immediate structural mutations were found. A finding of note 
was the over representation of the rs112626388 mutation that occurred 17% more often 
in our patients than in the general population. The 3’ UTR plays a crucial role in gene 
expression and have been shown to play an irreplaceable role in post translational 
regulation of gene expression (Matoulkova et al., 2012). Compromise of this region 
could have a powerfully adverse effect on the viability and efficacy of the mRNA and 
in turn the downstream processes. Collagen turn over in the IVD is suspected to take 
over 100 years, so it is unlikely that a 3’UTR in COL1A1 variant would heavily impact 
remodeling, however, if the fibers were initial improperly trafficked, this could affect 
the structural integrity of the disc. Based on the over representation of this suspected 
gene in a highly susceptible population seems to merit further research into the 
COL1A1 3’ UTR. COL9A2 and COL9A3 are heterotrimeric proteins found in small 
quantities in the NP and AF that are thought to function as an intermediary between 
collagens and noncollagenous proteins (Aspberg et al., 2012). The rare COL9A2 
variant rs140041506 was overrepresented in the patient population. In this variant an 
AA in the triple helical region is changed from nonpolar to polar. Collagen is composed 
of three subunits that are woven together to form the characteristic triple helix. The 
fibers must remain highly structured to maintain viability in the IVD, as previously 
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discussed; damage to the IVD is synergistic. A shift from one AA class to another 
could have serious consequences on structural integrity due to alterations in the shape 
of the coil as the previously sequestered residue is exposed to the hydrophilic exterior. 
This would cause structural compromise as the adhesion between collagen and the 
tissue broke down, resulting in failure of the AF. This process is under continued 
investigation and future studies should continue this course. Speaking to the efficacy of 
the study the rs61734651 allele was highly over represented as it was found in 20% of 
patients, while expected in less than 3%. This variant has been described as the Trp3 
allele and previously associated with IVDD (Paassilta et al., 2001), though a conclusive 
link has proven difficult to establish. A likely pathology of this variant would be similar 
to the compromise of induced by rs140041506. COL11A1 and COL11A2 are 
heterotrimeric fibers that are secreted as procollagen into the ECM and participate in 
matrix fiber formation (Aspberg et al., 2012). The COL11A1 allele rs36076089 was 
found to be over represented and affects the splice region. This variant may represent a 
less stable alternative splice variants that leads to ECM fiber formation that is less 
structurally sound. The rs2229784 COL11A2 allele was over represented and is 
characterized a shift from a hydrophobic residue to a hydrophilic residue in the triple 
helix domain. This would affect the stability of the helix in a manner similar to that 
found in the COL9A2 rs140041506 variant.   
4.2 Interleukin Findings 
 There were no significant findings for IL-1 or IL-6 variants. Increased expression 
levels are seen with IVDD and a plausible pathology exists, as previously discussed. 
Several Variants have been described and associated in previous studies (Solovieva et 
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al., 2004; Noponen-Hietala et al., 2005) further investigation with a larger cohort is 
merited.  
4.3 Vitamin D Receptor Findings 
 The VDR has been associated with IVDD in previous studies (Kawaguchi et al., 
2002; Cheung et al., 2006), and is known to play a role in bone mineralization and 
remodeling. The VDR is a steroid nuclear receptor and thus accurate localization and 
trafficking is crucial for proper functioning. Two patients presented with two identical 
3’ UTR variants, one variant has not been previously characterized and the other lacks 
proper population data, so statistical significance is difficult to ascertain. Of particular 
note however, is these mutations are 1 nucleotide apart. MiRNA recognize a 6 
nucleotide seed region (Matoulkova et al., 2012) and compromising a third of this 
sequence would interfere with binding and consequently regulation. Further research 
into the role of the VDR 3’UTR and IVDD is required before any conclusions can be 
drawn. 
4.4 Insulin-like Growth Factor Receptor Findings 
 IGF1R can regulate IVD ECM degradation and plays an important role in the 
normal functioning of the disc tissues and has previously been associated with IVDD 
(Urano et al., 2008). Several IGF1Rvariants were found to be over represented 
particularly rs35715134 and rs3051367. These are both variants of the 3’UTR and 
could play a role in altering proper IGR mediated MMP regulation leading to disc 
degeneration as discussed earlier. It is noteworthy that rs35715134 has an allele 
frequency of 49% in the American population, but was found in 14 of the 15 patients in 
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this study. This study has produced evidence that further genetic studies into IVDD 
etiology should certainly consider IGF1R variants. 
4.5 Aggrecan Findings 
Aggrecan is the primary hydrating agent of the IVD and as previously discussed, 
is central to IVDD onset and progression. ACAN variations were found in substantially 
higher abundance than variant alleles in any other investigated genes. Although 
absolute variant number can be accounted for due to the existence of more ACAN 
variants than in the other genes, several of these genes were found in much higher 
concentration than the established allele frequencies would predict. The rs938608 and 
rs938609 alleles were both found to be overrepresented and both found in the same 11 
patients, these variations are located 26 nucleotides apart on the same chromosome thus 
recombination is unlikely and a coupled inheritance is expected. The variant rs2882676 
however was found in 10 of the 11 individuals possessing rs938609 and rs938608 but is 
located almost 2000 base pairs away and is also over represented in the cohort. These 
variants are all found in the CS domains which code for one of the hydroscopic GAG 
components of aggrecan; chondroitin. Compromise of this protein inhibits the ability of 
the IVD to imbibe water and has been shown in studies to induce disc degeneration 
(Hadjipavlou et al., 2008). The alleles rs28559926 and rs3743398, also reside in the CS 
domain and were found to be over represented in our study. Two variants were found to 
be under represented rs11638262 and rs35430524. These alterations would be found in 
the CS and G3 structural domain respectively. The rs35430524 allele is a discrete 
alteration between aspartate and glutamate and is unlikely to affect tertiary or 
quaternary structure (Uitterlinden et al., 2004) and perhaps represents a more stable 
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conformation with superior hydroscopic characteristics. The rs11638262 allele affects 
the G3 globular domain which is involved in of the binding of GAGs, the shift from a 
hydrophobic alanine to a hydrophilic threonine could allow for improved GAG binding, 
leading to increased NP hydration. Further investigation of CS domain variants in 
certainly merited with a special emphasis on rs938609, rs938608, and rs2882676. 
4.6 Matrix Remodeling Enzyme Findings 
 There were no statistically relevant findings for MMP variants. Although 
upregulating of the MMPs is highly implicated in IVD ECM degradation, as previously 
discussed, and has been characterized in literature (Chen et al., 2006), a definitive 
genetic link has yet to be established, and perhaps upstream elements and indirect 
regulators should be investigated. THBS2 is an important modulator of MMP2 and 
MMP9 levels, and thus the compromise of THBS2 expression could result in the 
observed MMP mediated ECM degradation found in IVDD. The variant rs151019608 
is an alteration of 3’UTR and was found to be over represented in the study and 
consequently could play a role in aberrant MMP activation leading to IVDD.   
4.7 Limitations and Conclusion 
 Identification of the genetic components of IVDD is a crucial element to 
elucidating a pathophysiology and for early detection of disc degeneration. A literature 
review of IVDD was conducted and 5 genes that have probable roles in IVDD and have 
previously been associated with the disease were selected for investigation. Due to wide 
variation in radiographic diagnosis of IVDD, a lumbar HNP in the absence of trauma or 
other risk factors was determined to be a definitive indication of IVDD. Due to the rarity 
of lumbar HNP without risk factors the study was heavily limited to only 15 patients. The 
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validity of the inclusion criteria was heavily supported by the over representation of the 
COL9A3 rs61734651 allele which has previously been indicated in IVDD. The IGF1R 
variant rs35715134 was also heavily over represented in our patient population and could 
contribute to IVDD progression through improper mediation of ECM turnover. Finally 
the aggrecan variants rs938609, rs938608, and rs2882676 were found substantially over 
represented and likely influence the ability of the disc to synthesize viable chondroitin 
monomers contributing to poor hydration of the NP and ultimately structural failure of 
the IVD. These aberrations are in pathways strongly associated IVDD. These findings 
are, however limited in scope of applicability due to the small sample size employed and 
the age of the patients. As previously noted, IVDD is poorly understood and 
characterized, thus it is conceivable that this term actually encompasses several 
manifestation of degeneration, each with discrete pathologies. If this were the case, the 
above variants may only be applicable as genetic risk factors to an atraumatic early 
manifestation of IVDD. This supposition would help to explain the presence of 
previously reported rare variants such as rs61734651 but the lack of consistently reported 
inflammatory variants. Baring these limitations in mind, future studies on the genetic 
elements of an early presentation of IVDD should be conducted on a large sample of 
young adults who have had minimal to no exposure to suspected risk factors but have 
suffered a lumbar HNP and should focus on alterations of collagen, the insulin-like 
growth factor receptor, and aggrecan.   
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